drugset / Trial / NCT00174733

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

NCT00174733

Phase 3 Completed 456 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the efficacy of ciclesonide MDI either as once daily or a twice daily regimen in patients with mild to moderate asthma, who have previously been treated with an inhaled corticosteroid.

Timeline

Start
2005-07
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclesonide Other / unclassified 80 ug Inhaled
Subject Ciclesonide Other / unclassified 160 ug Inhaled

Indications